CJ Cheiljedang Balance Sheet Health
Financial Health criteria checks 3/6
CJ Cheiljedang has a total shareholder equity of ₩11,779.9B and total debt of ₩9,199.7B, which brings its debt-to-equity ratio to 78.1%. Its total assets and total liabilities are ₩29,606.3B and ₩17,826.3B respectively. CJ Cheiljedang's EBIT is ₩1,291.6B making its interest coverage ratio 2.8. It has cash and short-term investments of ₩2,128.8B.
Key information
78.1%
Debt to equity ratio
₩9.20t
Debt
| Interest coverage ratio | 2.8x |
| Cash | ₩2.13t |
| Equity | ₩11.78t |
| Total liabilities | ₩17.83t |
| Total assets | ₩29.61t |
Recent financial health updates
Recent updates
Why We're Not Concerned About CJ Cheiljedang Corporation's (KRX:097950) Share Price
Mar 01
Robust Earnings May Not Tell The Whole Story For CJ Cheiljedang (KRX:097950)
Mar 25Shareholders Are Loving CJ Cheiljedang Corporation's (KRX:097950) 0.8% Yield
Mar 18Is There An Opportunity With CJ Cheiljedang Corporation's (KRX:097950) 46% Undervaluation?
Mar 03Returns On Capital At CJ Cheiljedang (KRX:097950) Paint An Interesting Picture
Feb 16Do Institutions Own CJ Cheiljedang Corporation (KRX:097950) Shares?
Feb 01
Does CJ Cheiljedang (KRX:097950) Have A Healthy Balance Sheet?
Jan 17Are Robust Financials Driving The Recent Rally In CJ Cheiljedang Corporation's (KRX:097950) Stock?
Jan 02CJ Cheiljedang Corporation (KRX:097950) Is An Attractive Dividend Stock - Here's Why
Dec 15Are Investors Undervaluing CJ Cheiljedang Corporation (KRX:097950) By 46%?
Nov 27Financial Position Analysis
Short Term Liabilities: A097950's short term assets (₩9,133.9B) do not cover its short term liabilities (₩9,536.3B).
Long Term Liabilities: A097950's short term assets (₩9,133.9B) exceed its long term liabilities (₩8,290.1B).
Debt to Equity History and Analysis
Debt Level: A097950's net debt to equity ratio (60%) is considered high.
Reducing Debt: A097950's debt to equity ratio has reduced from 108% to 78.1% over the past 5 years.
Debt Coverage: A097950's debt is well covered by operating cash flow (26.6%).
Interest Coverage: A097950's interest payments on its debt are not well covered by EBIT (2.8x coverage).